Evidence map›Paper›PMID 37232919›Full record

ArticleBiosensors2023

Plasmonic Biosensor on the End-Facet of a Dual-Core Single-Mode Optical Fiber.

Fatemeh Fouladi Mahani, Arash Mokhtari, Pierre Berini

Abstract read
In one paragraph

Article in Biosensors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fatemeh Fouladi MahaniOptical and RF Communication Systems (ORCS) Lab, Electrical Engineering Department, Shahid Bahonar University of Kerman, Kerman 7616913439, Iran.ORCID 0000-0001-6567-3247
Arash MokhtariOptical and RF Communication Systems (ORCS) Lab, Electrical Engineering Department, Shahid Bahonar University of Kerman, Kerman 7616913439, Iran.ORCID 0000-0002-4792-736X
Pierre BeriniDepartment of Physics, School of Electrical Engineering and Computer Science, University of Ottawa, Ottawa, ON K1N 6N5, Canada.ORCID 0000-0002-6795-7275

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optical biosensors target widespread applications, such as drug discovery, medical diagnostics, food quality control, and environmental monitoring. Here, we propose a novel plasmonic biosensor on the end-facet of a dual-core single-mode optical fiber. The concept uses slanted metal gratings on each core, interconnected by a metal stripe biosensing waveguide to couple the cores via the propagation of surface plasmons along the end facet. The scheme enables operation in transmission (core-to-core), thereby eliminating the need to separate the reflected light from the incident light. Importantly, this simplifies and reduces the cost of the interrogation setup because a broadband polarization-maintaining optical fiber coupler or circulator is not required. The proposed biosensor enables remote sensing because the interrogation optoelectronics can be located remotely. In vivo biosensing and brain studies are also enabled because the end-facet can be inserted into a living body, once properly packaged. It can also be dipped into a vial, precluding the need for microfluidic channels or pumps. Bulk sensitivities of 880 nm/RIU and surface sensitivities of 1 nm/nm are predicted under spectral interrogation using cross-correlation analysis. The configuration is embodied by robust and experimentally realizable designs that can be fabricated, e.g., using metal evaporation and focused ion beam milling.

Indexed as

Biosensing TechniquesOptical FibersMicrofluidicsbiosensorsdual-core optical fiberslab-on-a-fiberplasmonics

Identifiers

PMID37232919
PMCPMC10216087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.